Discrimination between Breast Cancer Cells and White Blood Cells by Non-Invasive Measurements: Implications for a Novel In Vitro-Based Circulating Tumor Cell Model Using Digital Holographic Cytometry

• Published in: Applied sciences 2020-07, Vol.10 (14)
• Main Authors: Schich, Zahra El, Janicke, Birgit, Alm, Kersti, Dizeyi, Nishtman, Persson, Jenny L, Wingren, Anette Gjorloff
• Format: Article
• Language: English
• Subjects: Breast cancer; Cancer cells; Comparative analysis; Diagnosis; Flow cytometry; Holography in medicine; Leukocytes; Measurement; Technology application
• ISSN: 2076-3417; 2076-3417
• DOI: 10.3390/appl0144854

Breast cancer is the second most common cancer worldwide. Metastasis is the main reason for death in breast cancer, and today, there is a lack of methods to detect and isolate circulating tumor cells (CTCs), mainly due to their heterogeneity and rarity. There are some systems that are designed to detect rare epithelial cancer cells in whole blood based on the most common marker used today, the epithelial cell adhesion molecule (EpCAM). It has been shown that aggressive breast cancer metastases are of non-epithelial origin and are therefore not always detected using EpCAM as a marker. In the present study, we used an in vitro-based circulating tumor cell model comprising a collection of six breast cancer cell lines and white blood cell lines. We used digital holographic cytometry (DHC) to characterize and distinguish between the different cell types by area, volume and thickness. Here, we present significant differences in cell size-related parameters observed when comparing white blood cells and breast cancer cells by using DHC. In conclusion, DHC can be a powerful diagnostic tool for the characterization of CTCs in the blood. Keywords: breast cancer; cell area; cell thickness; cell volume; circulating tumor cell; CD45; digital holographic cytometry; EpCAM